# Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)

> **NCT00318162** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 50 (estimated)

## Conditions studied

- Pervasive Developmental Disorder

## Interventions

- **DRUG:** low dose naltrexone

## Key facts

- **NCT ID:** NCT00318162
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2006-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318162, "Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00318162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*